LCTX icon

Lineage Cell Therapeutics
LCTX

Overview Fund Trends Analyst Outlook Journalist POV

58 hedge funds and large institutions have $65.6M invested in Lineage Cell Therapeutics in 2013 Q2 according to their latest regulatory filings, with 58 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
58
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$196K
Puts
$775K
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$35.7M
2
$6.01M
3
$5.11M
4
$3.65M
5
$3.46M
6
$2.35M
7
$1.83M
8
$1.76M
9
$638K
10
$580K
11
$514K
12
$490K
13
$379K
14
$289K
15
$255K
16
$204K
17
$200K
18
$191K
19
$142K
20
$118K
21
$118K
22
$105K
23
$105K
24
$102K
25
$92K
1
2 3